Tuesday, July 28, 2020 Daily Archives

COVID-19: ‘Pandemic-ready’ set-up placing Emergent apart in CDMO space

by

Emergent BioSolutions is at the frontline of COVID-19, supporting vaccine candidate production for AstraZeneca, J&J, and others. Head of Emergent’s CDMO business explains why. Before January, the biologics contract development and manufacturing organization (CDMO) landscape was “very, very exciting,†Syed Husain, senior vice president and CDMO business unit head at Emergent, tells Bioprocess Insider over a Zoom interview. On the drug substance side, there was a healthy amount of demand for capacity coming from industry with a lot of opportunities…

July 28, 2020

Danaher: Integrating Cytiva in the time of coronavirus

by

Cytiva, the former GE Healthcare Life Sciences business, is “off to a blistering start†at Danaher, according to an analyst despite face-to-face restrictions imposed by COVID-19. For the second quarter 2020, Danaher Corporation reported revenues of $5.3 billon, up 19% year-on-year. This was attributed to high sales across its life sciences services divisions, including a boost from Cytiva – previously known as the Biopharma Business of GE Life Sciences – which Danaher acquired for $21 billion and became part of…

July 28, 2020